StockData
TFXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

TELEFLEX INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$129.68−0.75 (-0.58%)

Close on Oct 19, 2026

Market cap
$5.66B
P/E (TTM)
–
Dividend yield
1.05%

About Teleflex

Surgical & Medical Instruments & Apparatus, SIC 3841

Teleflex Incorporated designs, develops, manufactures, and supplies medical technology products, concentrating primarily on single-use devices for critical care and surgical applications. Its core product categories comprise vascular and emergency medicine, interventional devices, and surgical instruments, including catheters, intraosseous access systems, hemostatic products, vascular closure devices, and ligating clips. The company operates through three reportable segments: Americas, EMEA, and Asia. Teleflex markets and sells these items to hospitals and healthcare providers globally through direct sales personnel, independent representatives, and distributor networks.

The company operates globally, with major manufacturing facilities in the Czech Republic, Malaysia, Mexico, and the United States. As of December 31, 2025, Teleflex employed approximately 15,500 people, comprising 3,700 workers in the United States and 11,800 across 38 other nations. The provided text details international commercial operations and supply chains across these territories, though it does not state the company's specific headquarters location.

Summary of the business section of Teleflex's latest annual report, written by StockData.

Company profile

Company

Legal name
TELEFLEX INC
Founded
1943
Headquarters
Wayne, PA
Address
550 E Swedesford Rd, Suite 400 19087
Phone
(610) 225-6800
Employees
15,500, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Philadelphia, Pennsylvania

Stock & identifiers

Ticker
TFX
Exchange
NYSE
Shares outstanding
42M, Aug 4, 2026
Public float
$2.30B, Jun 29, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, Jun 17, 1997; 3-for-2, Jun 17, 1991; 2-for-1, Jun 17, 1986; 3-for-2, Sep 16, 1981; 2-for-1, Dec 16, 1980
SEC CIK
96943
CUSIP
879369106
ISIN
US8793691069
LEI
UUL85LWXB4NGSWWXIQ25
EIN
23-1147939

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Jason R. WeidmanPresident and CEO, Director53,983
Liam KellyChairman, President & CEO, Director64,584
Dominik Michal ReterskiCorporate Vice President, QARA7,198
John DerenExecutive Vice President & CFO18,077
Cameron P. HicksCorp. VP & Chief HR Officer19,400
James WintersCorp VP, Mfg and Supply17,760
Daniel V. LogueCVP, General Counsel & Secty24,959
Thomas E. PowellExecutive Vice President & CFO21,865
Jay WhiteCVP & Pres, Global Commercial9,218
Sean SalmonDirector674
Stuart A. RandleDirector16,524
Michael J. TokichDirector1,090
Candace H. DuncanDirector7,039
Gretchen R. HaggertyDirector7,395
Neena M. PatilDirector3,716
Andrew A. KrakauerDirector8,309
Jaewon RyuDirector4,817
John C. HeinmillerDirector5,040
Stephen K. M.D. KlaskoDirector17,213

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Liam J. Kelly
$6.73M$1.84M$1.70M$31$123
FY2024
Liam J. Kelly
$9.20M$2.74M$2.52M$48$135
FY2023
Liam J. Kelly
$9.04M$9.26M$2.33M$67$123
FY2022
Liam J. Kelly
$8.19M$5.01M$2.05M$67$112
FY2021
Liam J. Kelly
$8.67M$4.24M$2.07M$88$142
FY2020
Liam J. Kelly
$6.33M$4.83M$1.60M$110$119

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we employed approximately 15,500 employees, including 3,700 employees in the U.S.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 3, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 2, 2017Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 4, 2017Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 21, 2017Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 20, 2015MergerRegistration of securities for a merger or exchange offer (S-4)
Dec 8, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 26, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 28, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 24, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 26, 2010Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jul 22, 2010Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 25, 2009Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 3, 2008Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 10, 2007Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 1, 2007Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 13, 2006Late filingNotification of late filing
Sep 22, 2004Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 14, 1998ListingRegistration of securities on an exchange (Form 8-A)